{
  "General": [
    "Cancer Type",
    "Generic Name",
    "Combined With",
    "Mechanism of Action",
    "Line of Treatment",
    "Trial Name",
    "Development Stage US"
  ],
  "Efficacy": [
    "Primary Endpoint",
    "Objective Response Rate (ORR)",
    "Progression-Free Survival (PFS)",
    "Hazard Ratio (HR) PFS",
    "Complete Response (CR)",
    "Difference in PFS",
    "Duration of Response (DOR) Rate"
  ],
  "Safety": [
    "Incidence of Treatment-Emergent Adverse Events Leading to Death",
    "Thrombocytopenia",
    "Neutropenia",
    "Diarrhea",
    "Constipation",
    "Cough",
    "Pyrexia"
  ],
  "Timelines": [
    "First Results Announced",
    "Study Start Date",
    "Study Completion Date",
    "US Filing Date",
    "EU Filing Date",
    "China Filing Date",
    "US Approval Date"
  ]
}